Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase <scp>II</scp> trial (<scp>JMTO LC14</scp>‐01)Susumu Takeuchi, Masaaki Kawahara, Shunichi Sugawara et al.|Cancer Medicine|2023Cited by 8